X
Record #54073

Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression

Publisher
Elsevier
Original paper date
Sep 14, 2020
Institution
Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran · Department of Hematology and Blood Banking, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran · Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran · Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran · Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran · Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran · Department of Chemical and Materials Engineering, The University of Alabama in Huntsville, AL 35899, USA · Bioclinicum, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden · Immunogenetic Research Center, Mazandaran University of Medical Sciences, Sari, Iran · Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj. Iran · Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Open access
No
Article type
Research Article
Broad categories
(BLS) Biochemistry(BLS) Biology - Cancer(HSC) Medicine - Drug Design(PHY) Nanotechnology
Notes from Retraction Watch

see also: https://pubpeer.com/publications/1F09D4725ABA5D7DBC759B75FCCD6F#1

Citation lifecycle

How this paper is being cited

Pre-retraction
22
Same day
0
Post-retraction
8
% post-retraction
26.7%
~5.9 citations/yr before retraction · ~3.5 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse